Dr. Stuart Cockerill
Chief Scientific Officer, Founder
Spearheaded the GSK erbB2 Oncology Project Team that discovered Tykerb™ for metastatic breast cancer.
Dr. Rachel Harland
Head of Preclinical Development
Built value for two top-tier biotech companies via pivotal drug development strategies.
Dr. Seth Hetherington
Chief Medical Officer
Word class pediatric infectious disease physician – led clinical development of multiple therapeutic vaccines at Genocea Biosciences.
Dr. Eddy Littler
Chief Operating Officer
Led the identification and development of OlysioTM for chronic hepatitis C virus.
Dr. Neil Mathews
Project Director, Founder
Led deal-critical Hepatitis C project at Arrow Therapeutics prior to acquisition by AstraZeneca.
Alan A. Musso
Chief Financial Officer
Secured $150M financing and prepared Peloton Therapeutics for IPO — laying groundwork for Merck & Co. acquisition.
Alex C. Sapir
Chief Executive Officer
Grew small biotech start-up with upside to 150-person, publicly-traded company with approved, marketed product.
Dr. Elaine Thomas
Head of Virology
Advanced from Harvard Medical School post-doctoral fellowship to lead multiple preclinical & clinical virology studies.